Zusammenfassung
Die Vulvodynie (vulväre Dysästhesie) bezeichnet mehr als 3 Monate bestehende vulväre Schmerzen (Brennen, Stechen, Reizung sowie Wundsein) des äußeren weiblichen Genitales ohne vorliegende dermatologische oder gynäkologische Ursachen („brennende Vulva“). Unter der primären Vulvodynie werden die vulväre Vestibulitis und die essenzielle (dysästhetische) Vulvodynie verstanden. Die vulväre Vestibulitis ist durch Dyspareunie, Allodynie und ein vulväres Erythem gekennzeichnet. Die meisten Patientinnen sind kaukasischer Herkunft, prämenopausal und sexuell aktiv. Die Prävalenz wird mit bis zu 15% angegeben. Es findet sich ein übersteigertes Schmerzempfinden als Ursache oder Folge einer Schädigung des sympathischen Nervensystems von meist brennendem Charakter. Die psychische Beeinträchtigung, die sich bei vielen Patientinnen findet, ist jedoch eher als Folge der chronischen Beschwerden anzusehen. Die essenzielle Vulvodynie beschreibt demgegenüber ein vulväres Brennen, das nicht auf das Vestibulum beschränkt ist. Die Patientinnen sind hier meist älter, und die Dyspareunie ist weniger schwer ausgeprägt. Die Prävalenz der essenziellen Vulvodynie liegt zwischen 1 und 3%. Verschiedene interdisziplinäre therapeutische Maßnahmen gegen diese beiden relativ häufigen Genitalerkrankungen werden diskutiert.
Abstract
Vulvodynia (vulvar dysesthesia) refers to vulvar pain (burning, irritation and rawness) of the external female genitalia for more than 3 months without other dermatological or gynecological causes. The term primary vulvodynia should be reserved for vulvar vestibulitis and essential (dysesthetic) vulvodynia. Vulvar vestibulitis is characterized by dyspareunia, allodynia and vulvar erythema. Most patients are Caucasian, premenopausal and sexually active. The prevalence is estimated as high as 15%. Damage to the sympathetic nerves with an increased pain sensitivity is the likely explanation for the burning sensation. Psychological impairment, which is common in many patients, rather seems to be the consequence of the chronic disease than a primary condition. Essential vulvodynia is characterized by vulvar burning, which is characteristically not limited to the vestibulum. The patients are generally older and dyspareunia is less severe. The prevalence of essential vulvodynia is 1–3%. Various interdisciplinary approaches to these two rather frequent genital diseases are discussed.
Literatur
Aikens JE, Reed BD, Gorenflo DW, Haefner HK (2003) Depressive symptoms among women with vulvar dysesthesia. Am J Obstet Gynecol 189:462–466
Baggish MS, Sze EH, Johnson R (1997) Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol 177:507–511
Bergeron C, Moyal-Barracco M, Pelisse M, Lewin P (1994) Vulvar vestibulitis. Lack of evidence for a human papillomavirus etiology. J Reprod Med 39:936–938
Chadha S, Gianotten WL, Drogendijk AC et al. (1998) Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol 17:7–11
Danielsson I, Sjoberg I, Wikman M (2000) Vulvar vestibulitis: medical, psychosexual and psychosocial aspects, a case-control study. Acta Obstet Gynecol Scand 79:872–878
Denbow ML, Byrne MA (1998) Prevalence, causes and outcome of vulval pain in a genitourinary medicine clinic population. Int J STD AIDS 9:88–91
Friedrich EG Jr (1987) Vulvar vestibulitis syndrome. J Reprod Med 32:110–114
Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS (2002) Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 186:696–700
Glazer HI (2000) Dysesthetic vulvodynia. Long-term follow-up after treatment with surface electromyography-assisted pelvic floor muscle rehabilitation. J Reprod Med 45:798–802
Goetsch MF (1991) Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol 164:1609–1614
Granot M, Friedman M, Yarnitsky D, Zimmer EZ (2002) Enhancement of the perception of systemic pain in women with vulvar vestibulitis. Br J Obstet Gynaecol 109:863–866
Gunter J, Brewer A, Tawfik O (2004) Botulinum toxin a for vulvodynia: a case report. J Pain 5:238–240
Harlow BL, Stewart EG (2003) A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 58:82–88
Lundqvist EN, Hofer PA, Olofsson JI, Sjoberg I (1997) Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol 77:319–322
Masterson BJ, Galask RP, Ballas ZK (1996) Natural killer cell function in women with vestibulitis. J Reprod Med 41:562–568
McKay M (1984) Burning vulva syndrome, report of the ISSVD taskforce. J Reprod Med 29:457
McKay M (1993) Dysesthetic („essential“) vulvodynia. Treatment with amitriptyline. J Reprod Med 38:9–13
Peckham BM, Maki DG, Patterson JJ, Hafez GR (1986) Focal vulvitis: a characteristic syndrome and cause of dyspareunia. Features, natural history, and management. Am J Obstet Gynecol 154:855–864
Powell J, Wojnarowska F (1999) Acupuncture for vulvodynia. J R Soc Med 92:579–581
Reed BD, Haefner HK, Cantor L (2003) Vulvar dysesthesia (vulvodynia). A follow-up study. J Reprod Med 48:409–416
Scheinfeld N (2003) The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int J Dermatol 42:491–495
Turner ML, Marinoff SC (1991) Pudendal neuralgia. Am J Obstet Gynecol 165:1233–1236
Tympanidis P, Terenghi G, Dowd P (2003) Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 148:1021–1027
Zolnoun DA, Hartmann KE, Steege JF (2003) Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 102:84–87
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hengge, U.R., Runnebaum, I.B. Vulvodynie. Hautarzt 56, 556–561 (2005). https://doi.org/10.1007/s00105-005-0970-1
Issue Date:
DOI: https://doi.org/10.1007/s00105-005-0970-1